10-86710080-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_007078.3(LDB3):​c.1231+30C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0359 in 1,608,826 control chromosomes in the GnomAD database, including 1,286 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.051 ( 298 hom., cov: 33)
Exomes 𝑓: 0.034 ( 988 hom. )

Consequence

LDB3
NM_007078.3 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.212

Publications

2 publications found
Variant links:
Genes affected
LDB3 (HGNC:15710): (LIM domain binding 3) This gene encodes a PDZ domain-containing protein. PDZ motifs are modular protein-protein interaction domains consisting of 80-120 amino acid residues. PDZ domain-containing proteins interact with each other in cytoskeletal assembly or with other proteins involved in targeting and clustering of membrane proteins. The protein encoded by this gene interacts with alpha-actinin-2 through its N-terminal PDZ domain and with protein kinase C via its C-terminal LIM domains. The LIM domain is a cysteine-rich motif defined by 50-60 amino acids containing two zinc-binding modules. This protein also interacts with all three members of the myozenin family. Mutations in this gene have been associated with myofibrillar myopathy and dilated cardiomyopathy. Alternatively spliced transcript variants encoding different isoforms have been identified; all isoforms have N-terminal PDZ domains while only longer isoforms (1, 2 and 5) have C-terminal LIM domains. [provided by RefSeq, Jan 2010]
LDB3 Gene-Disease associations (from GenCC):
  • myofibrillar myopathy 4
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • familial dilated cardiomyopathy
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 10-86710080-C-G is Benign according to our data. Variant chr10-86710080-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257339.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.102 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LDB3NM_007078.3 linkc.1231+30C>G intron_variant Intron 9 of 13 ENST00000361373.9 NP_009009.1 O75112-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LDB3ENST00000361373.9 linkc.1231+30C>G intron_variant Intron 9 of 13 1 NM_007078.3 ENSP00000355296.3 O75112-1

Frequencies

GnomAD3 genomes
AF:
0.0510
AC:
7761
AN:
152106
Hom.:
295
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.105
Gnomad AMI
AF:
0.0286
Gnomad AMR
AF:
0.0228
Gnomad ASJ
AF:
0.0637
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0232
Gnomad FIN
AF:
0.0209
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0352
Gnomad OTH
AF:
0.0407
GnomAD2 exomes
AF:
0.0328
AC:
7748
AN:
236054
AF XY:
0.0322
show subpopulations
Gnomad AFR exome
AF:
0.108
Gnomad AMR exome
AF:
0.0190
Gnomad ASJ exome
AF:
0.0643
Gnomad EAS exome
AF:
0.000167
Gnomad FIN exome
AF:
0.0181
Gnomad NFE exome
AF:
0.0339
Gnomad OTH exome
AF:
0.0371
GnomAD4 exome
AF:
0.0343
AC:
49908
AN:
1456602
Hom.:
988
Cov.:
33
AF XY:
0.0342
AC XY:
24761
AN XY:
724604
show subpopulations
African (AFR)
AF:
0.103
AC:
3454
AN:
33432
American (AMR)
AF:
0.0195
AC:
865
AN:
44428
Ashkenazi Jewish (ASJ)
AF:
0.0596
AC:
1552
AN:
26048
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39620
South Asian (SAS)
AF:
0.0292
AC:
2508
AN:
85920
European-Finnish (FIN)
AF:
0.0208
AC:
1043
AN:
50150
Middle Eastern (MID)
AF:
0.0681
AC:
391
AN:
5744
European-Non Finnish (NFE)
AF:
0.0339
AC:
37699
AN:
1111106
Other (OTH)
AF:
0.0397
AC:
2390
AN:
60154
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
2673
5345
8018
10690
13363
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1410
2820
4230
5640
7050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0511
AC:
7784
AN:
152224
Hom.:
298
Cov.:
33
AF XY:
0.0482
AC XY:
3588
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.105
AC:
4343
AN:
41542
American (AMR)
AF:
0.0227
AC:
347
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0637
AC:
221
AN:
3470
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5172
South Asian (SAS)
AF:
0.0239
AC:
115
AN:
4818
European-Finnish (FIN)
AF:
0.0209
AC:
222
AN:
10608
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.0352
AC:
2395
AN:
68000
Other (OTH)
AF:
0.0460
AC:
97
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
373
746
1119
1492
1865
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0265
Hom.:
20
Bravo
AF:
0.0534
Asia WGS
AF:
0.0290
AC:
101
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.2
DANN
Benign
0.68
PhyloP100
-0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11597201; hg19: chr10-88469837; API